REGN Nov 2024 1040.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:13AM EDT. Market open.
| Previous close | 33.26 |
| Open | 33.26 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 1,040.00 |
| Expiry date | 2024-11-15 |
| Day's range | 33.26 - 33.26 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GuruFocus.comDecoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
Insightful Analysis of Regeneron's Financials and Strategic Positioning
Investor's Business DailyRegeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Regeneron stock jumped early Thursday, bolstered by strong sales of a high-dose version of its blockbuster eye disease treatment, Eylea.
ZacksRegeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Regeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
© 2024 Yahoo. All rights reserved.